Close X
Tuesday, October 8, 2024
ADVT 
National

Pharmacare would cost public sector billions more a year, but save economy money: PBO

Darpan News Desk The Canadian Press, 12 Oct, 2023 01:43 PM
  • Pharmacare would cost public sector billions more a year, but save economy money: PBO

The parliamentary budget officer says a single-payer universal drug plan would cost federal and provincial governments an additional$11.2 billion in the first year, and $13.4 billion in five years.

The PBO released a report on Thursday that provides an estimate for the cost of a pharmacare program between 2024-25 and 2027-28. It follows up on a previous costing the PBO published in 2017 for a pharmacare plan. 

The new report calculates the incremental cost of the program, taking into account current spending by governments on public drug plans as well as revenue that would be generated from co-pays under a pharmacare plan.

The Liberals have promised to table pharmacare legislation this fall as part of the supply-and-confidence deal the government struck with the NDP.

Currently, Canadians pay for their prescription drugs through a mix of public plans, private insurance and out-of-pocket spending. 

Excluding hospital drugs, the PBO says total prescription drug spending was $36.6 billion in 2021-22, a 28 per cent increase from 2015-16. 

Of that amount, 46 per cent was covered by governments, 40 per cent by private insurers and 14 per cent was paid-out-of-pocket. 

Total spending on prescription drugs under a single-payer, universal pharmacare plan is expected to be $33.2 billion in 2024-25, rising to $38.9 billion in 2027-28.

However the report also said such a plan would lead to economy-wide savings even though it estimates the use of prescription drugs would rise 13.5 per cent.

That's because the report assumes that the implementation of a single-payer universal plan would allow for better price negotiations, leading to lower drug prices.

The PBO estimates cost savings on drug expenditures of $1.4 billion in 2024-25, with that figure increasing to $2.2 billion by 2027-28.

Parliamentary budget officer Yves Giroux says the economy-wide savings are lower than what was estimated in the previous report published in 2017, namely because his office now estimates smaller savings from stronger drug price negotiations.

The economy-wide savings calculation does not take into account potential health care system savings from the rise in prescription drug use. Giroux said his office does not take on those kinds of cost-benefit analyses, which can be challenging to do. 

In a statement Thursday, the Canadian Life and Health Insurance Association said shifting from private to public coverage for pharmaceuticals is a bad move.

"A single-payer program will spend unnecessary billions to disrupt existing workplace health benefit plans that are already making a larger number of prescription drugs more affordable for millions," said Stephen Frank, President and CEO of the Canadian Life and Health Insurance Association.

The implementation of a single-payer universal drug plan is expected to affect the private insurance industry, given there would be little need for private drug coverage.

Meanwhile, non-profit advocacy group The Council of Canadians welcomed the PBO's findings.

"The only real beneficiary of our current fragmented system is the pharmaceutical industry," a statement from the organization said. 

"We urge the Liberal government to introduce legislation for a public, universal, comprehensive pharmacare program without delay."

The PBO report also looks at alternative coverage plans, as the federal government continues to work on what form a pharmacare program could take.

A plan that only covers catastrophic medicines, a term used to describe expensive drugs that could cause financial hardship, would cost governments an additional $400 million in the first year and $2 billion in five years.

Meanwhile, a plan that covers only essential medicines, which refers to medicines that address the priority health-care needs of a population, would cost an additional $2.4 billion in the first year and $12.1 billion in five years. 

The federal New Democrats have rejected the first draft of the Liberals' pharmacare legislation, which NDP health critic Don Davies said the didn't meet expectations.

"It doesn't meet the New Democrats' red lines at this point," Davies said in an interview. "We're waiting for a next draft to come to us."

Davies said the NDP will accept nothing less than a commitment to pharmacare paid for and administered through the public single-payer system, though it doesn't have to happen all at once.

MORE National ARTICLES

BC Hydro seeing record consumption

BC Hydro seeing record consumption
B-C Hydro says it set a new record for the highest peak hourly demand in August on Monday night.  It comes as a heat wave sweeping across the southern half of B-C also sets records, including 37.5 Celsius in Port Alberni, breaking a benchmark set in 1933 and 30.6 Celsius at Yoho National Park, surpassing a mark set in 1930.

BC Hydro seeing record consumption

2 arrested in carjacking delivery van

2 arrested in carjacking delivery van
Two men who have been arrested for allegedly carjacking a delivery van in Richmond failed to consider that many of those vehicles come equipped with G-P-S tracking systems.  R-C-M-P say it happened on Sunday when the driver said his van was taken at gunpoint by two people wearing masks.

2 arrested in carjacking delivery van

Federal Liberals have gone more than six months without appointing ethics watchdog

Federal Liberals have gone more than six months without appointing ethics watchdog
Mario Dion retired in February after serving as the last permanent ethics and conflict-of-interest commissioner. A longtime staffer in that office, Martine Richard, took on an interim role in April — but she resigned within weeks amid controversy around the fact she is the sister-in-law of Intergovernmental Affairs Minister Dominic LeBlanc.

Federal Liberals have gone more than six months without appointing ethics watchdog

COVID-19 activity showing early signs that it may be increasing, new PHAC data says

COVID-19 activity showing early signs that it may be increasing, new PHAC data says
New data from the Public Health Agency of Canada suggests that COVID-19 infections may be slowly starting to rise again in Canada. On its website, the agency says there are signs of continued fluctuations in some COVID-19 activity indicators after a long period of gradual decline.  

COVID-19 activity showing early signs that it may be increasing, new PHAC data says

Another rate hike coming: Stats Can

Another rate hike coming: Stats Can
The inflation rate rose to 3.3 per cent in July, a development that economists warn spells bad news for the Bank of Canada. Forecasters say the latest report raises the odds of an interest rate hike next month, despite other signs of economic softening, including rising unemployment.  

Another rate hike coming: Stats Can

Heatwave breaks records in BC

Heatwave breaks records in BC
The Fraser Canyon communities of Lytton and Lillooet both broke the 40 C mark on Monday, with Lytton reaching 41.4 C and Lillooet slightly behind, while the southern Okanagan community of Osoyoos was expected to join the 40-plus club by the end of the day.

Heatwave breaks records in BC